It mimics estrogen in the body
Needed Research: Future studies should include randomized controlled trials in human osteoarthritis patients, comparing AOD-9604 to standard treatments like corticosteroids and hyaluronic acid
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Enter your email, and we'll deliver it straight to your inbox
Unlike many medications that target a single pathway, BPC-157 appears to act broadly, promoting healing in multiple tissues